This metabolic perturbation significantly downregulates the expression of intestinal tight junction proteins, particularly ZO-1 (Mishra et al., 2023), thereby initiating a multistep pathogenic cascade: (i) compromised intestinal barrier integrity promotes bacterial translocation and systemic dissemination of deleterious metabolites
These findings suggest that PICALM dysfunction-induced BBB impairment is a key contributor to cerebral iron deposition and reduced Tau clearance
The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the infectious diseases society of America
Concordant gene expression changes confirm that the ndufs2 -/- zebrafish CI disease model has utility to inform cellular pathophysiology, and potentially the efficacy of therapeutic candidates for human PMD when studied in zebrafish models
Research Compound Summary Compound: Ipamorelin CAS Number: 170851-70-4 Molecular Formula: C38H49N9O5 Purity: 98.9% (HPLC verified) Third-Party Testing: Testides Analytical (independent lab, Toronto) COA Verification: Testides.com/verify Batch: MRL-IPA-0326 Source: Canadian manufactured Shipping: Same-day from our BC facility Ipamorelin peptide Canada: a selective growth hormone secretagogue pentapeptide developed for research into pulsatile GH release mechanisms